Korean pharmaceutical firms seeking to acquire promising bioventure companies

Published: 2008-06-05 07:00:00
Updated: 2008-06-05 07:00:00
Domestic drug makers are focusing on investment or acquisition for promising biopharmaceutical companies with platform technologies as part of efforts to survive in an era of free trade deals with foreign countries.

Local pharmaceutical companies have been largely dependent on producing and ma...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.